GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rebus Hldgs Inc (OTCPK:RBSH) » Definitions » E10

Rebus Hldgs (Rebus Hldgs) E10 : $-161,732.00 (As of Jun. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Rebus Hldgs E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Rebus Hldgs's adjusted earnings per share data for the three months ended in Jun. 2023 was $-0.001. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-161,732.00 for the trailing ten years ended in Jun. 2023.

During the past 3 years, the average E10 Growth Rate was 18.10% per year. During the past 5 years, the average E10 Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Rebus Hldgs was 18.10% per year. The lowest was 13.60% per year. And the median was 15.30% per year.

As of today (2024-05-21), Rebus Hldgs's current stock price is $0.0001. Rebus Hldgs's E10 for the quarter that ended in Jun. 2023 was $-161,732.00. Rebus Hldgs's Shiller PE Ratio of today is .


Rebus Hldgs E10 Historical Data

The historical data trend for Rebus Hldgs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rebus Hldgs E10 Chart

Rebus Hldgs Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -389,968.00 -326,006.00 -276,747.00 -236,872.00 -178,817.00

Rebus Hldgs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -210,319.00 -191,711.00 -178,817.00 -168,723.00 -161,732.00

Competitive Comparison of Rebus Hldgs's E10

For the Biotechnology subindustry, Rebus Hldgs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rebus Hldgs's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rebus Hldgs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rebus Hldgs's Shiller PE Ratio falls into.



Rebus Hldgs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rebus Hldgs's adjusted earnings per share data for the three months ended in Jun. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-0.001/128.7287*128.7287
=-0.001

Current CPI (Jun. 2023) = 128.7287.

Rebus Hldgs Quarterly Data

per share eps CPI Adj_EPS
201309 -62,812.500 98.790 -81,848.076
201312 -128,500.000 98.326 -168,232.764
201403 -121,250.000 99.695 -156,561.845
201406 -101,255.000 100.560 -129,619.027
201409 -94,368.400 100.428 -120,961.740
201412 -87,157.900 99.070 -113,250.804
201503 -101,255.000 99.621 -130,839.998
201506 -84,378.800 100.684 -107,881.928
201509 -62,409.100 100.392 -80,025.125
201512 -47,375.000 99.792 -61,112.090
201603 -20,416.700 100.470 -26,159.100
201606 -20,416.700 101.688 -25,845.849
201609 -50,875.000 101.861 -64,294.211
201612 -84,666.700 101.863 -106,997.303
201703 -84,378.000 102.862 -105,596.324
201706 -29,321.400 103.349 -36,521.902
201709 -54,001.900 104.136 -66,755.215
201712 -21,155.400 104.011 -26,182.851
201803 -1,168.950 105.290 -1,429.178
201806 195.799 106.317 237.074
201809 -7,028.950 106.507 -8,495.499
201812 1,404.520 105.998 1,705.713
201903 -29.251 107.251 -35.109
201906 -314.258 108.070 -374.333
201909 5.250 108.329 6.239
201912 -160.504 108.420 -190.569
202003 -27.001 108.902 -31.917
202006 -17.250 108.767 -20.416
202009 -0.020 109.815 -0.023
202012 -2.652 109.897 -3.106
202103 -3.640 111.754 -4.193
202106 0.446 114.631 0.501
202109 -0.010 115.734 -0.011
202112 -0.040 117.630 -0.044
202203 -0.020 121.301 -0.021
202206 -0.040 125.017 -0.041
202209 -0.001 125.227 -0.001
202212 0.020 125.222 0.021
202303 -0.010 127.348 -0.010
202306 -0.001 128.729 -0.001

Add all the adjusted EPS together and divide 10 will get our e10.


Rebus Hldgs  (OTCPK:RBSH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Rebus Hldgs E10 Related Terms

Thank you for viewing the detailed overview of Rebus Hldgs's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Rebus Hldgs (Rebus Hldgs) Business Description

Traded in Other Exchanges
N/A
Address
2629 Townsgate Road, Suite 215, Westlake Village, CA, USA, 91361
Rebus Hldgs Inc is an early-stage, pre-revenue, pharmaceutical company that is focused on the development of prodrug cancer therapeutics for the treatment of disease. The company along with its subsidiaries is engaged in the production of small-molecule adenosine receptor modulators. Adenosine is an extracellular signaling molecule that regulates multiple aspects of tissue function and specifically plays a role in immunity and inflammation.
Executives
John Robison Montgomery director 7647 BIRCHWOOD HILL RD, CROZET VA 22932
Richard E Buller director C/O CELCUITY INC., 16305 36TH AVE. N., #100, MINNEAPOLIS MN 55446
Claire Thom director 31200 VIA COLINAS, #200, WESTLAKE VILLAGE CA 91362
Ronald L Shazer officer: Chief Medical Officer C/O TRACON PHARMACEUTICALS, INC., 8910 UNIVERSITY CENTER LANE, STE 700, SAN DIEGO CA 92122
Christopher P. Lowe director, officer: President and CEO 2511 N LOOP 1604,, SUITE 204, SAN ANTONIO TX 78258
Scott Varde Ogilvie director 10880 WILSHIRE BLVD, SUITE 950, LOS ANGELES CA 90024
Bo Jesper Hansen director BIRKENWEG 16, MEGGEN V8 6045
Peter E Grebow director 41 MOORES ROAD, FRAZER PA 19355
Craig A Dionne director, 10 percent owner, officer: CEO,CFO, President 9901 IH 10 WEST, SUITE 800, SAN ANTONIO TX 78230
Russell Richerson 10 percent owner, officer: COO, Secretary 2511 N LOOP 1604 W, SUITE 204, SAN ANTONIO TX 78258
Kihong Kwon 10 percent owner 1015 E. CHAPMAN AVE, SUITE 201, FULLERTON CA 92831